Market Research Logo

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

The global market for selected healthcare-acquired infection (HAI) treatments was valued at nearly $15.2 billion in 2014. This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

This report provides:

Forecasts of the markets for healthcare-acquired infection (HAI) devices, pharmaceuticals, and therapies by treatment segment and treatment type, including supporting analyses for projections

Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020

Valuable tools for anyone assessing the HAI market and attempting to devise a strategy to successfully compete in the industry

Information needed to understand the current market and to address the emerging market.


SCOPE AND FORMAT

This report offers forecasts by treatment segment and type of treatment, from 2015 through 2020, including supporting analyses for projections.

The main market segments are analyzed by pharmaceutical treatments, environmental treatments and infection control devices/products.

This report is a valuable tool for anyone assessing the HAI market and attempting to devise a strategy to successfully compete in this market. This report provides background on the structure of the HAI market and the chief challenges and opportunities it faces. It offers the information needed to understand the current market and to address the emerging one.

The report is an invaluable tool for business planners, acquisition specialists, licensing strategists, product managers, market research analysts, investing consultants and others interested in the HAI market, its products, its participants and its future.

CHAPTER 1 INTRODUCTION
REASONS FOR DOING THE STUDY
STUDY GOALS AND OBJECTIVES
SCOPE AND FORMAT
METHODOLOGIES AND INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
SUMMARY TABLE GLOBAL MARKET FOR SELECTED HAI TREATMENTS, THROUGH 2020 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET SHARES OF HAI TREATMENTS BY GEOGRAPHICAL AREA, 2015 AND 2020 (%)
CHAPTER 3 GLOBAL HAI OVERVIEW
RISKS FOR ACQUIRING HAI
MOST COMMON HEALTHCARE-ASSOCIATED INFECTIONS
TABLE 1 CAUSES AND TYPES OF MOST COMMON HEALTHCARE-ACQUIRED
INFECTIONS
GRAM-POSITIVE BACTERIA
S. AUREUS
Transmission Routes
MRSA
Transmission Routes
PNEUMONIA
Pseudomonas Aeruginosa
Hospital-Acquired Pneumonia (HAP)
K. Pneumonia
CLOSTRIDIUM DIFFICILE
E. COLI
UTI Treatment Options
GASTROENTERITIS-CAUSING BACTERIA
Treatment Options
VANCOMYCIN-RESISTANT ENTEROCOCCI (VRE)
Types of VRE
LEGIONELLA BACTERIA
Treatment Options
GRAM-NEGATIVE BACTERIA
PSEUDOMONAS AERUGINOSA
ACINETOBACTER BAUMANNII
CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE)
VIRAL INFECTIONS
HEPATITIS C
Scope of Infection
Treatment
NOROVIRUS
INFLUENZA VIRUS
Influenza Virus A, B, C
Transmission
Symptoms
Treatment
FUNGAL INFECTIONS
MEDICAL NEED FOR ANTIFUNGALS
ASPERGILLUS INFECTIONS
Treatment
YEAST INFECTIONS
CANDIDA INFECTIONS
PREVENTING HAI
DETERMINING THE MODE OF TRANSMISSION
ROLES OF HEALTHCARE INSTITUTIONS AND INFECTION CONTROL
INDIVIDUALS
TABLE 2 SELECTED RESPONSIBILITIES OF INFECTION CONTROL TEAM
MEMBERS
COMPONENTS OF A HAI SURVEILLANCE SYSTEM
TABLE 3 MAIN STEPS AND COMPONENTS IN DEVELOPING AN EFFECTIVE
INFECTION CONTROL SURVEILLANCE SYSTEM
HEALTHCARE INFECTION POINTS OF GENERATION
HOSPITAL
FIGURE 1 OCCURRENCE OF HAI IN U.S. HOSPITALS BY TYPE, 2011 (%)
Hospital Surgical Procedures
AMBULATORY SURGERY CENTERS IN THE U.S.
Infection Control in ASCs
DIALYSIS CENTERS
Transmission of VRE in Dialysis Centers
Hepatitis Transmission in Dialysis Centers
ASSISTED LIVING/LONG-TERM CARE FACILITIES
PROACTIVE TREATMENTS
THE IMPORTANCE OF HAND WASHING
CDC RECOMMENDATIONS FOR PREVENTION
TABLE 4 CDC MEASURES FOR PREVENTION OF HEALTHCARE-ACQUIRED
INFECTIONS
TABLE 5 PERCENTAGE DECREASE IN HAI IN U.S. HOSPITAL SETTINGS, 2008-2013 (%)
ENVIRONMENTAL CONTROLS
DEVICE DESIGN
HUMAN AND MONETARY COSTS OF HAI
U.S. HEALTHCARE SPENDING
U.S. HEALTHCARE SPENDING ON HAI
TABLE 6 ESTIMATED COSTS OF HAI IN U.S. HOSPITALS, 2012 (PER PATIENT OCCURRENCE) ($)
EMRA
JAPAN
RATE OF INFECTION
CHINESE MARKET
CHANGES IN THE HEALTHCARE INDUSTRY
TABLE 7 SELECTED MERGERS AND/OR ACQUISITIONS, 2010-2015 ($ MILLIONS)
REGULATIONS
AMERICAS
Creating Drug Treatments
TABLE 8 PROCESS OF CREATING DRUG TREATMENTS IN THE U.S.
Infection Control Measures/Protocols
U.S. REGULATIONS
Hospital Infections Disclosure Act (HIDA)
Current and Pending Requirements
Affordable Care Act and Implications for the Pharmaceutical Industry
Biosimilars
CMS Reimbursement for HAI
"Never Events" Reimbursement
Generating Antibiotics Incentives Now Act (2012)
BRAZILIAN REGULATIONS
EUROPEAN REGULATIONS
Innovative Medicines Initiative (IMI)
Implications for Pharmaceutical Manufacturers
JAPANESE REGULATIONS
CHINESE REGULATIONS
CHAPTER 4 HAI PHARMACEUTICAL MARKET
TABLE 9 BACTERIA THAT COMMONLY CAUSE HAI
PHARMACEUTICALS USED FOR HAI
TABLE 10 GLOBAL MARKET FOR HAI PHARMACEUTICALS BY TYPE, THROUGH 2020 ($ MILLIONS)
VIRAL HAI PHARMACEUTICALS
TABLE 11 SELECTED VIRAL HAI PHARMACEUTICALS BY NAME, INDICATION AND MANUFACTURER, 2014
VIRAL PHARMACEUTICAL MARKET BY COMPANY
FIGURE 2 GLOBAL MARKET SHARES OF HEPATITIS, INFLUENZA AND PNEUMONIA PHARMACEUTICALS TO TREAT HAI BY COMPANY, 2014 (%)
VIRAL PHARMACEUTICAL MARKET BY CONDITION
TABLE 12 GLOBAL MARKET FOR PHARMACEUTICALS TO TREAT VIRAL HAI BY CONDITION, THROUGH 2020 ($ MILLIONS)
FIGURE 3 GLOBAL MARKET SHARE FOR HAI VIRAL PHARMACEUTICALS, BY DISEASE TYPE, 2014 (%)
BACTERIAL HAI
THE THREAT OF ANTIBIOTIC RESISTANCE
THE MICROBIOLOGY OF BACTERIAL RESISTANCE
MECHANISMS OF RESISTANCE
TABLE 13 ANTIBIOTIC CLASSES AND THEIR MODE OF ACTION
METHODS OF RESISTANCE
Beta-Lactamase Production
Importing Resistance from Other Organisms
Alteration of Binding Sites to Circumvent Anti-infective Effectiveness
Antibiotic Discharge
PRIMARY REASONS FOR ANTIBIOTIC RESISTANCE
Incomplete Course of Prescribed Medicine
Overuse of Broad-Spectrum Antibiotics
Antibiotics and Food Production Animals
TABLE 14 ANTIBIOTICS APPROVED FOR USE IN FOOD-PRODUCING ANIMALS BY DRUG CLASS, POUNDS USED, AND PERCENTAGE OF TOTAL, 2009 (POUNDS/%)
Patient Pressure
RESISTANCE BY CLASS OF ANTIBIOTIC
TABLE 15 ANTIBIOTIC RESISTANT ORGANISMS AND DRUG CLASSES
AFFECTED
BACTERIAL HAI PHARMACEUTICALS
TABLE 16 SELECTED BACTERIAL HAI PHARMACEUTICALS BY NAME, INDICATION AND MANUFACTURER, 2014
CLASSES OF DRUGS
Aminoglycosides
B-lactam Antibiotics
Cephalosporins
Glycopeptides
Lincosamides
Lipopeptides
Carbapenems
Penicillins
Polypeptides
Macrolides
Quinolones
Tetracyclines
Sulfonamides
Other Formulations
GLOBAL MARKET SHARE FOR BACTERIAL PHARMACEUTICALS BY COMPANY FIGURE 4 GLOBAL MARKET SHARES OF HAI BACTERIAL PHARMACEUTICALS BY COMPANY, 2014 (%)
BACTERIAL PHARMACEUTICAL MARKET BY TYPE
TABLE 17 GLOBAL MARKET FOR PHARMACEUTICALS TO TREAT BACTERIAL HAI, THROUGH 2020 ($ MILLIONS)
FUNGAL HAI PHARMACEUTICALS
TABLE 18 SELECT LISTING OF PHARMACEUTICALS TO TREAT FUNGAL INFECTIONS BY NAME, TYPE AND MANUFACTURER, 2014
TABLE 19 GLOBAL MARKET FOR PHARMACEUTICALS TO TREAT FUNGAL HAI, THROUGH 2020 ($ MILLIONS)
FUNGAL PHARMACEUTICAL MARKET BY COMPANY
FIGURE 5 GLOBAL MARKET SHARES OF PHARMACEUTICALS TO TREAT FUNGAL HAI, BY COMPANY, 2014 (%)
GLOBAL OPPORTUNITIES
GLOBAL GROWTH RATES FOR PHARMACEUTICALS
ROLE OF EMERGING COUNTRIES IN GLOBAL MARKETS
PHARMACEUTICAL SALES IN EMERGING NATIONS
REGIONAL ANALYSIS
GLOBAL MARKET FOR HAI PHARMACEUTICALS
TABLE 20 GLOBAL MARKET FOR HAI PHARMACEUTICALS BY REGION, THROUGH 2020 ($ MILLIONS)
AMERICAS
TABLE 21 AMERICAS MARKET FOR PHARMACEUTICAL PRODUCTS DESIGNED TO MINIMIZE HAI BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 22 AMERICAS MARKET FOR PHARMACEUTICAL PRODUCTS DESIGNED TO MINIMIZE HAI BY TYPE, THROUGH 2020 ($ MILLIONS)
FIGURE 6 AMERICAS HAI PHARMACEUTICAL MARKET SHARES, BY DISEASE TYPE, 2015 AND 2020 (%)
EMRA
TABLE 23 EMRA MARKET FOR PHARMACEUTICAL PRODUCTS DESIGNED TO MINIMIZE HAI BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 24 EMRA MARKET FOR PHARMACEUTICAL PRODUCTS DESIGNED TO MINIMIZE HAI, BY TYPE, THROUGH 2020 ($ MILLIONS)
FIGURE 7 EMRA HAI PHARMACEUTICAL MARKET SHARES BY DISEASE TYPE, 2015 AND 2020 (%)
ASIA
Japan
Hepatitis in Japan
China
Hepatitis in China
Surgical Site Infections in China
India
Australia
TABLE 25 ASIAN MARKET FOR PHARMACEUTICAL PRODUCTS DESIGNED TO MINIMIZE HAI BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 26 ASIAN MARKET FOR PHARMACEUTICAL PRODUCTS DESIGNED TO MINIMIZE HAI, BY TYPE, THROUGH 2020 ($ MILLIONS)
FIGURE 8 ASIAN HAI PHARMACEUTICAL MARKET SHARES BY DISEASE TYPE, 2015 AND 2020 (%)
CHAPTER 5 HAI ENVIRONMENTAL TREATMENT MARKET
GLOBAL HAI ENVIRONMENTAL TREATMENT MARKET
TABLE 27 GLOBAL MARKET FOR ENVIRONMENTAL PRODUCTS DESIGNED TO MINIMIZE HEALTHCARE-ACQUIRED INFECTIONS BY TYPE, THROUGH 2020 ($ MILLIONS)
AIR TREATMENT
ROOM FILTRATION SYSTEMS
ROOM PRESSURIZATION
HYDROGEN PEROXIDE VAPOR (HPV)
ULTRAVIOLET (UV) LIGHT DISINFECTION
WATER TREATMENT
DESIGN OF SINKS AND OTHER WATER FACILITIES
LEVELS OF CLEANING
ENVIRONMENTAL CLEANING
TABLE 28 SURVIVAL OF HOSPITAL PATHOGENS ON DRY HOSPITAL
SURFACES
DISINFECTION
Levels of Disinfection
Disinfectant Drying Time
TABLE 29 ADVANTAGES/DISADVANTAGES OF COMMONLY USED
DISINFECTANTS
Cleaning Monitoring
Disinfectants
Phenolics
Oxidizing Agents
Halogens
Aldehydes
Ortho-phthalaldehyde (OPA)
Quaternary Ammonium Compounds
Bleach
Alcohols
TABLE 30 GLOBAL MARKET FOR DISINFECTANT PRODUCTS DESIGNED TO MINIMIZE HEALTHCARE-ACQUIRED INFECTIONS, THROUGH 2020 ($ MILLIONS)
Antimicrobial Copper Surface Coatings
PATIENT SKIN PREPARATION
POVIDONE-IODINE SOLUTIONS
CHLOROHEXIDINE GLUCONATE
TABLE 31 GLOBAL MARKET FOR PATIENT SKIN PREPARATION DISINFECTANTS, THROUGH 2020 ($ MILLIONS)
STERILIZATION SYSTEMS FOR INFECTION CONTROL
TABLE 32 GLOBAL MARKET FOR MEDICAL STERILIZATION PRODUCTS DESIGNED TO MINIMIZE HEALTHCARE-ACQUIRED INFECTIONS, THROUGH 2020 ($ MILLIONS)
FILTRATION
TABLE 33 GLOBAL MARKET OF IN-LINE MEDICAL FILTERS USED IN CONJUNCTION WITH MEDICAL ADMINISTRATION OF SOLUTIONS, THROUGH 2020 ($ MILLIONS)
CHEMICAL STERILIZATION
TABLE 34 GLOBAL MARKET FOR MEDICAL CHEMICAL STERILIZATION EQUIPMENT AND CONSUMABLES, THROUGH 2020 ($ MILLIONS)
EtO Sterilization
Other Types of Chemical Sterilization
Hydrogen Peroxide
Ozone
Chlorine Dioxide
Major Manufacturers in Chemical Sterilization
STEAM STERILIZATION
TABLE 35 GLOBAL MARKET FOR MEDICAL STEAM STERILIZATION EQUIPMENT AND CONSUMABLES, THROUGH 2020 ($ MILLIONS)
TABLE 36 SELECTED MATERIALS THAT RESPOND WELL TO STEAM
STERILIZATION
Autoclaving
Major Players in Heat Sterilization
RADIATION STERILIZATION
TABLE 37 GLOBAL MARKET FOR RADIATION STERILIZATION PRODUCTS DESIGNED TO MINIMIZE HEALTHCARE-ACQUIRED INFECTIONS BY TYPE, THROUGH 2020 ($ MILLIONS)
Gamma Radiation
Medical Uses
TABLE 38 MICROBES INACTIVATED BY GAMMA IRRADIATION AND THE AMOUNT OF NECESSARY KGY
TABLE 39 MEDICAL GRADE POLYMERS CAPABLE OF TOLERATING
GAMMA RADIATION (KGY)
Electron-Beam Radiation
REGIONAL ANALYSIS
TABLE 40 GLOBAL MARKET FOR ENVIRONMENTAL PRODUCTS/ EQUIPMENT TO CONTROL HAI, BY REGION, THROUGH 2020 ($ MILLIONS)
AMERICAS
TABLE 41 AMERICAS MARKET FOR ENVIRONMENTAL PRODUCTS/EQUIPMENT TO CONTROL HAI BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 42 AMERICAS MARKET FOR ENVIRONMENTAL PRODUCTS DESIGNED TO MINIMIZE HEALTHCARE-ACQUIRED INFECTIONS BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
EMRA
Patient Skin Preparation Solutions
EMRA Market for Environmental Products/Equipment
TABLE 43 EMRA MARKET FOR ENVIRONMENTAL PRODUCTS/EQUIPMENT TO CONTROL HAI BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 44 EMRA MARKET FOR ENVIRONMENTAL PRODUCTS DESIGNED TO MINIMIZE HEALTHCARE-ACQUIRED INFECTIONS, THROUGH 2020 ($ MILLIONS)
ASIA
TABLE 45 ASIAN MARKET FOR ENVIRONMENTAL PRODUCTS/EQUIPMENT TO CONTROL HAI, THROUGH 2020 ($ MILLIONS)
TABLE 46 ASIAN MARKET FOR ENVIRONMENTAL PRODUCTS DESIGNED TO MINIMIZE HEALTHCARE-ACQUIRED INFECTIONS, THROUGH 2020 ($ MILLIONS)
CHAPTER 6 HAI MEDICAL DEVICES: CATHETERS, PATIENT VENTILATION
SYSTEMS AND IN-LINE STERILIZATION FILTERS
TABLE 47 GLOBAL MARKET FOR MEDICAL DEVICES THAT ARE DESIGNED TO MINIMIZE HAI, THROUGH 2020 ($ MILLIONS)
ANTIMICROBIAL COATINGS
CATHETERS
FIGURE 9 MAJOR NOSOCOMIAL INFECTIONS IN U.S. ICU BY TYPE AND PERCENT (%)
CATHETER COATINGS
Common Antimicrobial Coatings
Nitrofurazone
Minocycline/Rifampin
Silver Coating
Combination Minocycline-Rifampin-Chlorhexidine Catheters
SURFACE-MODIFIED CATHETER
GLOBAL HAI CATHETER MARKET
TABLE 48 GLOBAL MARKET FOR CATHETERS WITH ANTIMICROBIAL
PROPERTIES BY TYPE, THROUGH 2020 ($ MILLIONS)
FIGURE 10 PROJECTED HAI CATHETER MARKET SHARES BY TYPE, 2015 AND 2020 (%)
URINARY TRACT CATHETERS
CENTRAL VENOUS CATHETERS
Dialysis Catheters
Catheter-Related Bloodstream Infections (CRBSI)
PERIPHERALLY INSERTED CENTRAL VENOUS CATHETERS (PICC)
MARKET OPPORTUNITIES FOR CATHETER MANUFACTURERS
TABLE 49 KEY MANUFACTURERS OF ANTIBIOTIC-COATED CATHETERS BY NAME, LOCATION AND PRODUCTS, 2014
CATHETER GROWTH IN REGIONAL MARKETS
TABLE 50 GLOBAL HAI CATHETER MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
FIGURE 11 PROJECTED GLOBAL HAI CATHETER MARKET SHARES BY REGION, 2015 AND 2020 (%)
PATIENT VENTILATION DEVICES
TABLE 51 GLOBAL MARKET FOR PATIENT VENTILATION PRODUCTS, THROUGH 2020 ($ MILLIONS)
TYPES OF VENTILATION DEVICES
Noninvasive Ventilators
PATIENT VENTILATION MARKET
TABLE 52 GLOBAL MARKET FOR NONINVASIVE VENTILATION SYSTEMS FOR USE WITH HAI-INFECTED PATIENTS, THROUGH 2020 ($ MILLIONS)
ENDOTRACHEAL TUBES AND VENTILATION SYSTEMS
Coated Endotracheal Tubes
Tapered Endotracheal Tubes
TABLE 53 GLOBAL MARKET FOR COATED ENDOTRACHEAL TUBES DESIGNED TO MINIMIZE VAP, THROUGH 2020 ($ MILLIONS)
IN-LINE STERILE IV FILTRATION
TABLE 54 GLOBAL STERILE IV FILTER MARKET, THROUGH 2020 ($ MILLIONS)
REGIONAL ANALYSIS
TABLE 55 GLOBAL MARKET FOR PATIENT INFECTION CONTROL DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
FIGURE 12 GLOBAL HAI PATIENT INFECTION CONTROL DEVICES MARKET SHARES BY REGION, 2015 AND 2020 (%)
THE AMERICAS
TABLE 56 AMERICAS MARKET FOR INFECTION CONTROL DEVICES DESIGNED TO MINIMIZE HAI, BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 57 AMERICAS MARKET FOR CATHETERS, PATIENT VENTILATION SYSTEMS AND IN-LINE STERILE FILTERS, THROUGH 2020 ($ MILLIONS)
EMRA
TABLE 58 EMRA MARKET FOR INFECTION CONTROL DEVICES DESIGNED TO MINIMIZE HAI, BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 59 EMRA MARKET FOR CATHETERS, PATIENT VENTILATION SYSTEMS AND IN-LINE STERILE FILTERS, THROUGH 2020 ($ MILLIONS)
ASIA
TABLE 60 ASIAN MARKET FOR INFECTION CONTROL DEVICES DESIGNED TO MINIMIZE HAI BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 61 ASIAN MARKET FOR CATHETERS, PATIENT VENTILATION SYSTEMS AND IN-LINE STERILE FILTERS, THROUGH 2020 ($ MILLIONS)
CHAPTER 7 CURRENT RESEARCH, EMERGING THERAPIES AND MARKET
OPPORTUNITIES
EMERGING RESEARCH
ANTIBACTERIAL SURFACES
FIM-D
BROAD SPECTRUM ANTIVIRAL
"NANOTRAPS"
FECAL PILLS TO TREAT C. DIFFICILE
PHARMACEUTICAL TREATMENT PRODUCT PIPELINE
TABLE 62 HAI PHARMACEUTICAL PRODUCT PIPELINE
FIGURE 13 MARKET SHARE BY TYPE OF PHARMACEUTICAL COMPOUND IN DEVELOPMENT, 2014 (%)
PHARMACEUTICAL RESEARCH
BACTERIAL INFECTIONS: PRODUCTS IN DEVELOPMENT
Achaogen
Melinata Therapeutics
GlaxoSmithKline (GSK)
Polyphor
The Medicines Company
Basilea Pharmaceuticals
Cempra Pharmaceuticals
Nabriva Therapeutics
Furiex Pharmaceuticals
Merck
Toyama Chemical
Crestone Pharma
Theravance Biopharma
Paratek Pharmaceuticals
AstraZeneca
Daiichi Sankyo
Roche
VIRAL INFECTIONS: PRODUCTS IN DEVELOPMENT
BioCryst Pharmaceuticals
Boehringer Ingelheim
Roche
Merck
Toyama Chemical
Gilead Sciences
Vertex
Bristol-Myers Squibb
OPPORTUNITIES/CHALLENGES FOR HAI INDUSTRY
CHALLENGES
PHARMACEUTICAL MARKET OPPORTUNITIES/CHALLENGES
Patent Expiry
TABLE 63 SELECTED HAI-RELATED PHARMACEUTICAL PATENT
EXPIRATIONS, 2004-2024
Pipeline Limitations
Regulatory Restrictions
Generic Competition
THE IMPACT OF DEMOGRAPHIC CHANGES
DEMOGRAPHIC CHANGES IN THE U.S.
DEMOGRAPHIC CHANGES OUTSIDE THE U.S.
CHAPTER 8 PATENTS
TABLE 64 NUMBER OF SELECTED PATENTS BY TYPE, JANUARY 2010 THROUGH FEBRUARY 2015
PATENTS BY DATE OF ISSUE
TABLE 65 PHARMACEUTICAL PATENTS BY DATE OF ISSUE, JANUARY 2010 THROUGH MARCH 2015
TABLE 66 ENVIRONMENTAL PATENTS* BY DATE OF ISSUE, JANUARY 2010
THROUGH MARCH 2015
TABLE 67 MEDICAL DEVICE PATENTS BY DATE OF ISSUE, JANUARY 2010
THROUGH MARCH 2015
NUMBER OF PATENTS BY MANUFACTURER
TABLE 68 NUMBER OF PATENTS BY MANUFACTURER, JANUARY 2010 THROUGH FEBRUARY 2015
PHARMACEUTICALS
BACTERIAL PHARMACEUTICAL PATENTS
TABLE 69 PATENTS ON BACTERIAL PHARMACEUTICALS, SEPTEMBER 2010 THROUGH MARCH 2015
FUNGAL PHARMACEUTICAL PATENTS
TABLE 70 PATENTS ON FUNGAL PHARMACEUTICALS, SEPTEMBER 2010 THROUGH FEBRUARY 2015
VIRAL PHARMACEUTICAL PATENTS
TABLE 71 PATENTS ON VIRAL PHARMACEUTICALS, JANUARY 2011 THROUGH MARCH 2015
ENVIRONMENTAL CONTROLS
AIR FILTRATION
TABLE 72 PATENTS ON AIR FILTRATION, FEB 2011-MARCH 2013
WATER FILTRATION
TABLE 73 PATENTS ON WATER TREATMENT, SEPTEMBER 2010 TO MARCH 2014
SOLID WASTE TREATMENT
TABLE 74 PATENTS ON SOLID WASTE TREATMENT, APRIL 2011 THROUGH DECEMBER 2014
SURFACE DISINFECTANTS
TABLE 75 PATENTS ON SURFACE DISINFECTANTS, JANUARY 2010 TO DECEMBER 2014
PATENTS FOR PATIENT DISINFECTION
TABLE 76 PATENTS ON PATIENT DISINFECTANTS, DECEMBER 2010 TO APRIL 2013
MEDICAL DEVICES
CATHETERS
TABLE 77 PATENTS ON CATHETERS, JULY 2010 TO FEBRUARY 2015
ANTIMICROBIAL COATINGS
TABLE 78 PATENTS ON ANTIMICROBIAL COATINGS, AUGUST 2010 THROUGH JANUARY 2015
CHAPTER 9 COMPANY DIRECTORY
PHARMACEUTICALS
ABBOTT LABORATORIES
Business Overview
Products
TABLE 79 ABBOTT HAI PRODUCTS
ABBVIE INC.
Business overview
Products
TABLE 80 ABBVIE HAI PRODUCTS
ACHAOGEN INC.
Business Overview
ACTAVIS PLC
Business Overview
Products
TABLE 81 ACTAVIS HAI PRODUCTS
ASTELLAS PHARMA INC.
Business Overview
Products
TABLE 82 ASTELLAS HAI PRODUCTS
ASTRAZENECA PLC
Business Overview
Products
TABLE 83 ASTRAZENECA HAI PRODUCTS
B. BRAUN MELSUNGEN
Business Overview
Products
TABLE 84 B. BRAUN HAI PRODUCTS
BACTIGUARD AB
Business Overview
Products
BASILEA PHARMACEUTICA LTD.
Business Overview
Products
TABLE 85 BASILEA HAI PRODUCTS
BAXTER INTERNATIONAL
Business Overview
BAYER AG (MILES-BAYER)
Business Overview
Products
TABLE 86 BAYER HAI PRODUCTS
BRISTOL-MYERS SQUIBB
Business Overview
Products
TABLE 87 BRISTOL MYERS SQUIBB HAI PRODUCTS
GILEAD SCIENCES
Business Overview
Products
TABLE 88 GILEAD SCIENCES HAI PRODUCTS
GLAXOSMITHKLINE
Business Overview
Products
TABLE 89 GLAXOSMITHKLINE HAI PRODUCTS
JANSSEN THERAPEUTICS (FORMERLY TIBOTEC THERAPEUTICS)
Business Overview
Products
TABLE 90 JANSSEN THERAPEUTICS HAI PRODUCTS
JOHNSON & JOHNSON
Business Overview
Products
TABLE 91 JOHNSON & JOHNSON HAI PRODUCTS
MELINTA THERAPEUTICS (FORMERLY RIB-X PHARMACEUTICALS)
Business Overview
MERCK
Business Overview
Products
TABLE 92 MERCK HAI PRODUCTS
NOVARTIS PHARMACEUTICALS
Business Overview
Products
TABLE 93 NOVARTIS HAI PRODUCTS
PARATEK PHARMACEUTICALS
Business Overview
PFIZER
Business Overview
Products
TABLE 94 PFIZER HAI PRODUCTS
ROCHE PHARMACEUTICALS
Business Overview
Products
TABLE 95 ROCHE HAI PHARMACEUTICAL PRODUCTS
SHIRE PLC
Business Overview
Products
TABLE 96 SHIRE HAI PHARMACEUTICAL PRODUCTS
SUN PHARMA
Business Overview
Products
TABLE 97 SUN PHARMA HAI PHARMACEUTICAL PRODUCTS
TETRAPHASE PHARMACEUTICALS
Business Overview
THE MEDICINE COMPANY
Business Overview
Products
TABLE 98 THE MEDICINE COMPANY HAI PHARMACEUTICAL
PRODUCTS
THERAVANCE BIOPHARMA
Business Overview
Products
TABLE 99 THERAVANCE HAI PRODUCTS
TOYAMA CHEMICAL CO. LTD.
Business Overview
Products
TABLE 100 TOYAMA CHEMICAL HAI PRODUCTS
VENUS REMEDIES LTD.
Business Overview
Products
TABLE 101 VENUS REMEDIES HAI PRODUCTS
ENVIRONMENTAL PRODUCTS
3M HEALTHCARE, MEDICAL DIVISION
Business Overview
Products
ADVANCED STERILIZATION PRODUCTS
Business Overview
Products
ANDERSEN PRODUCTS INC.
Business Overview
Products
BELIMED
Business Overview
Products
BETA STAR LIFE SCIENCE EQUIPMENT (R-V INDUSTRIES)
Business Overview
Products
BIOQUELL UK LTD.
Business Overview
Products
CONSOLIDATED STERILIZER SYSTEMS
Business Overview
Products
E-BEAM SERVICES INC.
Business Overview
Products
ECOLAB
Business Overview
Products
EOS SURFACES LLC
Business Overview
Product
GETINGE USA INC.
Business Overview
Products
IBA GROUP
Business Overview
Products
LTE SCIENTIFIC LTD.
Business Overview
Products
LUMALIER
Business Overview
Products
MESA LABORATORIES
Business Overview
Products
METREX RESEARCH
Business Overview
Products
NORION INC. (SEE STERIGENICS)
PRIMUS STERILIZER CO. INC.
Business Overview
Products
RUHOF CORP.
Business Overview
Products
SANOSIL INTERNATIONAL
Business Overview
Products
SEALED AIR CORP. (DIVERSEY CARE)
Business Overview
Products
STERIGENICS INTERNATIONAL INC.
Business Overview
Products
STERIS CORP.
Business Overview
Products
SYNERGY HEALTH STERILISATION UK LTD
Business Overview
Products
TERRAGENE SRL
Business Overview
Products
TSO3
Business Overview
Products
TUTTNAUER USA CO. LTD.
Business Overview
Products
ULTRAVIOLET DEVICES INC.
Business Overview
Products
XENEX DISINFECTION SERVICES
Business Overview
Products
INFECTION CONTROL PRODUCTS/DEVICES
B BRAUN MELSUNGEN AG
Business Overview
Products
BECTON DICKINSON
Business Overview
Products
CANTEL MEDICAL CORP.
Business Overview
Products
CAREFUSION CORP.
Business Overview
Products
CLOROX CO.
Business Overview
Products
COLOPLAST GROUP
Business Overview
Products
COOK MEDICAL
Business Overview
Products
COVIDIEN PLC (MEDTRONIC)
Business Overview
Products
C.R. BARD
Business Overview
Products
HALYARD HEALTH
Business Overview
Products
ONDINE BIOMEDICAL INC.
Business Overview
Products
ROCHESTER MEDICAL LTD.
Business Overview
Products
SCHULKE & MAYR GMBH
Business Overview
Products
TELEFLEX MEDICAL
Business Overview
Products
WELCH ALLYN INC.
Business Overview
Products

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report